SE443511B - Forfarande for framstellning av ett blodkoaguleringsbefremjande preparat ur humanblodplasma - Google Patents

Forfarande for framstellning av ett blodkoaguleringsbefremjande preparat ur humanblodplasma

Info

Publication number
SE443511B
SE443511B SE7707992A SE7707992A SE443511B SE 443511 B SE443511 B SE 443511B SE 7707992 A SE7707992 A SE 7707992A SE 7707992 A SE7707992 A SE 7707992A SE 443511 B SE443511 B SE 443511B
Authority
SE
Sweden
Prior art keywords
preparing
procedure
blood plasma
coagulation promotion
blood coagulation
Prior art date
Application number
SE7707992A
Other languages
English (en)
Swedish (sv)
Other versions
SE7707992L (sv
Inventor
J Eibl
O Schwarz
F Elsinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of SE7707992L publication Critical patent/SE7707992L/xx
Publication of SE443511B publication Critical patent/SE443511B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
SE7707992A 1976-08-30 1977-07-08 Forfarande for framstellning av ett blodkoaguleringsbefremjande preparat ur humanblodplasma SE443511B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Publications (2)

Publication Number Publication Date
SE7707992L SE7707992L (sv) 1978-03-01
SE443511B true SE443511B (sv) 1986-03-03

Family

ID=3585985

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7707992A SE443511B (sv) 1976-08-30 1977-07-08 Forfarande for framstellning av ett blodkoaguleringsbefremjande preparat ur humanblodplasma

Country Status (17)

Country Link
US (1) US4160025A (de)
AR (1) AR213861A1 (de)
AT (1) AT350726B (de)
BE (1) BE858031A (de)
CA (1) CA1079191A (de)
CH (1) CH635747A5 (de)
DE (1) DE2734821C3 (de)
DK (1) DK151932C (de)
ES (1) ES461918A1 (de)
FI (1) FI57421C (de)
FR (1) FR2362633A1 (de)
GB (1) GB1554051A (de)
HU (1) HU180816B (de)
LU (1) LU78024A1 (de)
NL (1) NL170922C (de)
NO (1) NO148142C (de)
SE (1) SE443511B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
DE3165600D1 (en) * 1980-01-28 1984-09-27 Baxter Travenol Lab Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
ATE15489T1 (de) * 1980-05-27 1985-09-15 Miles Lab Die blutkoagulation aktivierendes produkt und verfahren zu dessen herstellung.
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
JPS5866054A (ja) * 1981-10-14 1983-04-20 Sekisui Chem Co Ltd 血液検査用容器
JPS58105064A (ja) * 1981-12-17 1983-06-22 Sekisui Chem Co Ltd 血液凝固促進剤
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US5118614A (en) * 1988-01-18 1992-06-02 Tessek Sdruzeni Praha Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
EP0674531A1 (de) * 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
EP1528930B1 (de) * 2002-07-23 2009-04-15 Bio & Bio Licensing SA Thrombingenerierfähige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel
EP1523327A1 (de) * 2002-07-23 2005-04-20 Bio-Products & Bio-Engineering Aktiengesellschaft Thrombingenerierfahige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel
EP2305289A1 (de) 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Medizinische Produkte zur Behandlung von Blutgerinnungsstörungen
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью
JP2022041059A (ja) * 2020-08-31 2022-03-11 シスメックス株式会社 検量線の表示方法および分析装置
JP2025522101A (ja) 2022-07-12 2025-07-10 ビオメディツィニーシェ フォルシュング ウント ビオ－プロドゥクト ゲーエムベーハー 止血を促進するための薬剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
DD121793A1 (de) * 1975-07-17 1976-08-20
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process

Also Published As

Publication number Publication date
US4160025A (en) 1979-07-03
NO772978L (no) 1978-03-01
LU78024A1 (de) 1978-01-11
CA1079191A (en) 1980-06-10
ES461918A1 (es) 1978-12-16
DK151932B (da) 1988-01-18
ATA640576A (de) 1978-11-15
CH635747A5 (de) 1983-04-29
FR2362633A1 (fr) 1978-03-24
AT350726B (de) 1979-06-11
DK384577A (da) 1978-03-01
NL170922B (nl) 1982-08-16
FI57421B (fi) 1980-04-30
DE2734821B2 (de) 1980-11-06
BE858031A (fr) 1977-12-16
NO148142C (no) 1983-08-17
AR213861A1 (es) 1979-03-30
NL7708872A (nl) 1978-03-02
FR2362633B1 (de) 1981-06-12
DE2734821A1 (de) 1978-03-02
GB1554051A (en) 1979-10-17
NL170922C (nl) 1983-01-17
NO148142B (no) 1983-05-09
DE2734821C3 (de) 1985-03-14
SE7707992L (sv) 1978-03-01
HU180816B (en) 1983-04-29
FI772408A7 (fi) 1978-03-01
FI57421C (fi) 1980-08-11
DK151932C (da) 1988-06-20

Similar Documents

Publication Publication Date Title
NO148142C (no) Fremgangsmaate ved fremstilling av et blodkoaguleringsfremmende preparat fra humant blodplasma
NO773156L (no) Fremgangsmaate for fremstilling av funksjonelt protein
SE437767B (sv) Forfarande for framstellning av ett antitumorlekemedel
NO145915C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive karboksyalkylacylaminosyrer
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
SE7609316L (sv) Medicinsk inhalationsapparat for behandling av sjukdomar i andningsvegaran
NO153121C (no) Fremgansmaate for fremstilling av en liposomforloeper
NO137663C (no) Fremgangsmaate ved undersoekelse av ukoagulert blod
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO800186L (no) Fremstilling av et medisinsk preparat.
DK511576A (da) Fremgangsmade til at fremkalde storkning af blod
NO144030C (no) Fremgangsmaate til fremstilling av et matvareprodukt fra blod
NO140932C (no) Fremgangsmaate for fremstilling av lateks
SE426904B (sv) Forfarande for framstellning av en koagulerad eggviteprodukt
FI65370B (fi) Foerfarande foer framstaellning av ett fast farmaceutiskt preparat
SE7901980L (sv) Forfarande for framstellning av ostliknande produkter
SE7708692L (sv) Forfarande for framstellning av fiberarmerade cementprodukter
SE7707621L (sv) Forfarande for framstellning av xyloslosning
NO147523C (no) Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperidylindenderivat
SE442375B (sv) Forfarande for framstellning av en komposition for behandling av klimakteriska besver
NO149875C (no) Fremgangsmaate for fremstilling av insulin
NO139410C (no) Fremgangsmaate for fremstilling av lateks
NO144421C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive n-benzylaminosyrer

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7707992-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7707992-9

Format of ref document f/p: F